Healthcare Finance, Tax and Law Weekly

A.P. Pharma, Inc. - Pharmaceutical firm reports 7% increase in revenue; trials underway

aaiPharma Inc. - Pharmaceutical company completes $105M sale of MVI and Aquasol business

Aastrom Biosciences, Inc. - Biotech company reports loss of $0.03 per share

Abaxis, Inc. - Blood analysis systems maker reports 25% increase in revenue

Abgenix, Inc. - Therapeutic antibody developer reports loss f $0.47 per share, clinical update

Aclara BioSciences - Bioassay developer reports loss of $0.10 per share

Actelion Pharmaceuticals Ltd. - Pharmaceutical company adopts portfolio management solution

Advancis Pharmaceutical Corporation - Anti-infective drug maker reports $0.47 per share loss

Adventrx Pharmaceuticals, Inc. - American Stock Exchange lists stock of pharmaceutical firm

Aerogen, Inc. - Respiratory disease drug maker reports loss of $0.98 per share

Aksys, Ltd. - Dialysis systems developer reports loss of $0.23 per share

Alaris Medical Systems, Inc. - Device firm reports strong gains in first quarter performance

Alliance for Cancer Gene Therapy - $4 million in research grants awarded

Allied Healthcare Products, Inc. - Respiratory care product maker reports increased profit despite lower sales

Altana AG - Pharmaceutical company reports 5% increase in sales

- Flu-like virus breaks out in Bangladesh: mortality rates of 60-74% reported

aaiPharma, Inc. - Mayne completes acquisition of injectable multivitamin suite of products

Abiomed, Inc. - AB5000 circulatory support system launched

Able Laboratories, Inc. - FDA approval granted for Theophylline

Acute Coronary Syndrome - Women affected with ACS at older age than men, and have delayed treatment

Addiction Medicine - New research shows adult marijuana abuse and dependence increased during 1990s

Adherex Technologies, Inc. - New chief financial officer named at biopharmaceutical firm

Adolescent Health - Pregnancy, childbirth leading cause of girls' deaths in developing world

Advanced Bionics Corp. - FDA approves rechargeable implantable spinal cord stimulation system

Advanced Magnetics, Inc. - Ferumoxytol phase II hemodialysis data presented at clinical meeting

Advanced Magnetics, Inc. - Phase III trials of ferumoxytol initiated in IV iron replacement therapy

Advanced Medical Optics, Inc. - FDA approves StabilEyes capsular tension ring for cataract surgery

Adventist Health System - Florida hospital implements state-of-the-art call center solution

AEterna Laboratories, Inc. - Positive data reported from phase II trials of Cetrorelix in three indications

Agenzia Sanitaria Regione Emilia Romagna - Discharge diagnoses not suitable for monitoring surgical infections

AGT Biosciences Limited - Cross border merger creates integrated pharmaceutical firm

Aichi Cancer Center -  MASL1 oncogene involved in hematological and solid tumors

Akdeniz University - Long-term angiographic outcome after aneurysm surgery evaluated

Akita University - Mutant gap junction proteins alter liver cell activity

Albert Einstein College of Medicine - Medical, social risk factors tied to children's health status, utilization

Albert Einstein College of Medicine, New York - Cardiac disease in children may be related to primary glomerular disorders

Alcon, Inc. - FDA approval granted for a extra list of pathogens for Vigamox

Alexis Vautrin Center, Nancy - Wild-type p53 gene transfer sensitizes cancer to photodynamic therapy

Allergy Medicine - Large families and animals keep allergies at bay

Alpharma, Inc. - Agreement reached relating to gabapentin sales

Altarex Corp. - MAb prolongs disease-free survival in optimal chemosensitive patients

American Epilepsy Society - Epilepsy guidelines will improve treatment and access

American Medical Systems Holdings - Medical device firm reports 20% sales growth for first quarter

American Pharmaceutical Partners - FDA approves Cladribine injection for hairy cell leukemia

Amersham Health AS - Novel pH-sensitive paramagnetic liposomes have enhanced MRI properties

AmSurg Corp. - AmSurg reports 23% growth in net earnings

Amylin Pharmaceuticals, Inc. - Obesity drug maker reports loss of $0.40 per share, provides business update

Anadys Pharmaceuticals, Inc. - Anti-infective drug maker exercises underwriters' over-allotment option

Andrx Corporation - FDA approval granted for Fortamet; Altocor gets new name

Anika Therapeutics, Inc. - Therapeutic device firm reports 81% revenue increase to $6.1M

Ankara University - Cyclosporine reduces hepatic antioxidant capacity

Antares Pharma, Inc. - Pharmaceutical company adds new member to its board of directors

Anthropology - In U.S., who does housework affects whether couples have a second child

Anthropology - Talking to unborn child is a uniquely American practice

Apogent Technologies, Inc. - Device maker reports strong cash flow and margin improvement

Applied Biosystems - Genes associated with survival in diffuse large B cell lymphoma identified

Applied Biosystems Group - Biotech software firm reports earnings per share of $0.22

Aptamera, Inc. - Mark C. Rogers becomes chairman of oncology drug-development company

Aradigm Corporation - Interim analysis of initial pulmonary insulin phase III trial released

Ardais Corporation - Biorepository to be launched at Duke for clinical research in cancer

Aristotle University of Thessaloniki - Genetic blood disease produces silent strokes

Aristotle University of Thessaloniki - Wastewater treatment plant workers should receive hepatitis vaccines

Array BioPharma, Inc. - Douglas E. Williams named to board of directors at biotech firm

ArthroCare Corp. - Device company reports revenue growth of 31%

ARYx Therapeutics, Inc. - Phase I trial for ATI-7505 initiated for GI disorder

Assaf Harofeh Medical Center - Normal p21Ras/MAP kinase pathway found in polycystic ovary disease

Aston University - Nintendo games may cause epileptic seizures in photosensitive children

AstraZeneca - Genetic mutations of EGFR-TK confer responsiveness to Iressa

AstraZeneca - Research: ZOMIG nasal spray single dose is rapidly absorbed intranasally

Atherotech, Inc. - Agreement signed to use cholesterol test for drug development studies

Atrix Laboratories, Inc. - Tentative approval granted for Fluticasone cream

ATS Medical, Inc. - Heart valve maker acquires rights to new cardiac surgery technology

Australian Institute of Musculo-Skeletal Research - Hydroxyapatite-coated cementless TKR feasible in elderly patients

Australian National University - Flavavirus budding has incidental effect on MHC class I expression